KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1152 |
|---|---|
| Product Name | Anti-Human CD3E Recombinant Antibody(Otelixizumab) |
| Molecular Name | Otelixizumab |
| Alias | Anti-CD3E Recombinant Antibody, Research Grade Otelixizumab |
| CAS Number | 881191-44-2 |
| Target | CD3E[Homo sapiens] |
| Isotype | IgG1 Lambda |
| Clonity | Monoclonal |
| Host | Rat |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | FCM, IP, ELISA, Neut, FuncS, IF, WB |
| Buffer | PBS, pH7.5 |
| Background | Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
